药物对比
Repaglinide vs Pramlintide
Repaglinide是一种口服格列奈类药物，以葡萄糖依赖方式刺激胰岛素释放，用于2型糖尿病的餐时血糖控制；而Pramlintide是一种注射用胰淀素类似物，可延缓胃排空并降低餐后血糖，常作为胰岛素的辅助治疗，具有低血糖黑框警告。
此页面暂无可用的对比维度。
临床背景
Patients with type 2 diabetes may compare Repaglinide, an oral antidiabetic, and Pramlintide, an injectable amylin analog, when selecting between oral monotherapy and adjunct therapy options.
结论
Repaglinide and Pramlintide are distinct antidiabetic agents with different mechanisms and indications, and the choice depends on individual patient needs and treatment goals.
全部药物对比